Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 151-160 of 368

Page
per page
  1. Vemurafenib (PLX4032, RG7204)
    A3004 Vemurafenib (PLX4032, RG7204)
     9 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥24.5 mg/mL
  2. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     2 Citation
    Target: PI3K
    Summary: PI3K inhibitor
  3. (-)-Epigallocatechin gallate (EGCG)
    A2600 (-)-Epigallocatechin gallate (EGCG)
    Target: BACE
    Summary: Antioxidant, antiangiogenic and antitumor agent
      ≥22.9 mg/mL
  4. AS 602801
    A3189 AS 602801
    Summary: Jun Kinase Inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL
  5. AZD-9291
    B1104 AZD-9291
     1 Citation
    Target: EGFR
    Summary: Mutated forms EGFR inhibitor
      ≥24.98 mg/mL
  6. CO-1686 (AVL-301)
    A3320 CO-1686 (AVL-301)
     1 Citation
    Target: EGFR
    Summary: EGFR inhibitor
      ≥27.8 mg/mL
  7. Torin 1
    A8312 Torin 1
     7 Citation
    Target: mTOR
    Summary: MTOR inhibitor,potent and selective
  8. Palomid 529
    A8618 Palomid 529
    Summary: PI3K/Akt/mTOR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
  9. Galiellalactone
    C4650 Galiellalactone
    Summary: inhibits IL-6-mediated JAK/STAT signal transduction
      Soluble in ethanol;Soluble in methanol;Soluble in DMSO;Soluble in dimethyl formamide
  10. SB 216763
    A8240 SB 216763
     3 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor,ATP-competitive,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL

Items 151-160 of 368

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 4item
  2. Apoptosis 10item
  3. Chromatin/Epigenetics 45item
  4. Metabolism 5item
  5. MAPK Signaling 34item
  6. Tyrosine Kinase 92item
  7. DNA Damage/DNA Repair 8item
  8. PI3K/Akt/mTOR Signaling 58item
  9. Microbiology & Virology 1 item
  10. Cell Cycle/Checkpoint 8item
  11. Ubiquitination/ Proteasome 2item
  12. JAK/STAT Signaling 83item
  13. TGF-β / Smad Signaling 23item
  14. Angiogenesis 1 item
  15. GPCR/G protein 2item
  16. Stem Cell 39item
  17. Membrane Transporter/Ion Channel 3item
  18. Cancer Biology 12item
  19. Endocrinology and Hormones 16item
  20. Neuroscience 17item
  21. Obesity, Appetite Control & Diabetes 4item
  22. Other Signal Transduction 42item
  23. Others 12item
  24. Immunology/Inflammation 8item
  25. Cardiovascular 24item
Specificity
  1. Selective 110item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 10item
  2. Irreversible 6item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 9item
  4. PI3K 13item
  5. Raf 8item
  6. Aurora Kinases 1 item
  7. mTOR 8item
  8. Androgen Receptors 1 item
  9. FLT3 2item
  10. GSK-3 7item
  11. P-glycoprotein (P-gp) 1 item
  12. VEGFR 10item
  13. PDGFR 4item
  14. Phosphodiesterases (PDEs) 1 item
  15. p38 4item
  16. PKB 1 item
  17. JNK 4item
  18. Bcr-Abl 1 item
  19. MEK 5item
  20. PORCN 1 item
  21. FGFR 5item
  22. Nrf2 1 item
  23. GABAB Receptors 1 item
  24. Smoothened 1 item
  25. MET 1 item
  26. Src 3item
  27. Trk Receptors 1 item
  28. NMDA Receptors 1 item
  29. STAT 6item
  30. EGFR 23item
  31. Hedgehog 1 item
  32. BMP and Other Activin Receptors 2item
  33. JAK 19item
  34. Syk 2item
  35. DNA-PK 1 item
  36. HSP90 1 item
  37. TNKS 1 item
  38. ErbB 5item
  39. Toll-like receptors (TLRs) 1 item
  40. ERK 2item
  41. c-MET 1 item
  42. PKC 7item
  43. HER2 3item
  44. Melanocortin (MC) Receptors 1 item
  45. ALK 2item
  46. PKG 1 item
  47. PKA 4item
  48. Fatty-acid-binding proteins (FABPs) 1 item
  49. RSK 1 item
  50. Histamine H1 Receptors 1 item
  51. MNK 1 item
  52. NO Donors / Precursors 1 item
  53. IL Receptors 1 item
  54. AChE 1 item
  55. Insulin Receptors 1 item
  56. IRG-1R 1 item
  57. BACE 1 item
  58. c-RET 1 item
  59. p70 rsk 1 item
  60. sodium channels 1 item
  61. insulin 1 item
  62. Smoothened receptor 1 item
  63. Nrf2/ARE signal 1 item
  64. PPAR 1 item
  65. Antibiotic 1 item
  66. ErbB-2 1 item
  67. Prk 1 item
  68. ICAM 1 item
  69. Rho 1 item
  70. TYK2 2item
  71. MUSK 1 item
  72. MAP3K 1 item
  73. Thrombin Receptor 1 item
  74. prolactin secretion 1 item
  75. gonadotropin release 1 item
  76. TRPC channel 1 item
  77. FKBP 1 item
Reported Experiments
  1. Animal Experiments 152item
  2. Cell Experiments 118item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 2item
  4. Breast Cancer 27item
  5. Cancer 102item
  6. Cervical Cancer 2item
  7. Colon Cancer 10item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 11item
  10. Glioblastoma 11item
  11. Glioma 3item
  12. Heart Failure 1 item
  13. Hepatocellular Carcinoma 1 item
  14. HIV Infections 1 item
  15. Immunological Diseases 1 item
  16. Inflammatory Bowel Disease 1 item
  17. Leukemia 9item
  18. Liver Cancer 2item
  19. Lung Cancer 8item
  20. Lymphoma 3item
  21. Melanoma 6item
  22. Multiple Myeloma 2item
  23. Myelofibrosis 1 item
  24. Myeloma 1 item
  25. Neuroblastoma 2item
  26. Non-small Cell Lung Cancer 6item
  27. Ovarian Cancer 8item
  28. Pancreatic Cancer 11item
  29. Pancreatic Carcinoma 2item
  30. Prostate Cancer 14item
  31. Psoriasis 1 item
  32. Pulmonary Arterial Hypertension 1 item
  33. Pulmonary Fibrosis 1 item
  34. Renal Cancer 1 item
  35. Renal Cell Carcinoma 1 item
  36. Rheumatoid Arthritis 4item
  37. Thyroid Cancer 2item
  38. Type 2 Diabetes 2item